$ENTB Dr. Ichim has 20 years of biotechnology experience, including founding Immune Advisors LLC, a biotechnology consulting group focused on accelerating commercialization of companies in the regenerative medicine and immune-oncology space. Dr. Ichim previously served as Chief Scientific Officer and Chief Executive Officer of Medistem Inc. which was acquired by Intrexon Inc. He also co-founded bioRASI (a contract research organization), served as a Vice President of Cellular Therapies at Intrexon Inc. Dr. Ichim has more than 100 peer reviewed publications on cell therapy and immunology and over 100 patents and patent applications.

http://finance.yahoo.com/news/entest-biomedic...NlYwNzYw--